Xenon Pharmaceuticals Inc. (XENE) stock
XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
$38.78−0.48 (-1.22%)
Close on Nov 17, 2026Market cap $3.76BP/E –Yield –
Xenon Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Xenon Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$337.52M. For fiscal 2025 it was -$279.12M. The highest annual figure on record is $45.57M in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$279.12M | – |
| FY2024 | Dec 31, 2024 | -$181.39M | – |
| FY2023 | Dec 31, 2023 | -$151.11M | – |
| FY2022 | Dec 31, 2022 | -$101.03M | – |
| FY2021 | Dec 31, 2021 | -$69.50M | – |
| FY2020 | Dec 31, 2020 | -$48.12M | – |
| FY2019 | Dec 31, 2019 | -$4.71M | – |
| FY2018 | Dec 31, 2018 | -$34.72M | – |
| FY2017 | Dec 31, 2017 | -$28.73M | – |
| FY2016 | Dec 31, 2016 | -$19.57M | – |
| FY2015 | Dec 31, 2015 | -$18.10M | -6905.6% |
| FY2014 | Dec 31, 2014 | $266.00K | – |
| FY2013 | Dec 31, 2013 | -$3.32M | -107.3% |
| FY2012 | Dec 31, 2012 | $45.57M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$95.39M | – |
| Q1 FY2026 | Mar 31, 2026 | -$88.90M | – |
| Q4 FY2025 | Dec 31, 2025 | -$81.48M | – |
| Q3 FY2025 | Sep 30, 2025 | -$71.75M | – |
| Q2 FY2025 | Jun 30, 2025 | -$64.23M | – |
| Q1 FY2025 | Mar 31, 2025 | -$61.65M | – |
| Q4 FY2024 | Dec 31, 2024 | -$54.39M | – |
| Q3 FY2024 | Sep 30, 2024 | -$49.67M | – |
| Q2 FY2024 | Jun 30, 2024 | -$31.15M | – |
| Q1 FY2024 | Mar 31, 2024 | -$46.19M | – |
| Q4 FY2023 | Dec 31, 2023 | -$35.40M | – |
| Q3 FY2023 | Sep 30, 2023 | -$48.08M | – |
| Q2 FY2023 | Jun 30, 2023 | -$33.22M | – |
| Q1 FY2023 | Mar 31, 2023 | -$34.41M | – |
| Q4 FY2022 | Dec 31, 2022 | -$35.33M | – |
| Q3 FY2022 | Sep 30, 2022 | -$30.40M | – |
| Q2 FY2022 | Jun 30, 2022 | -$16.87M | – |
| Q1 FY2022 | Mar 31, 2022 | -$18.43M | – |
| Q4 FY2021 | Dec 31, 2021 | -$20.71M | – |
| Q3 FY2021 | Sep 30, 2021 | -$15.01M | – |
| Q2 FY2021 | Jun 30, 2021 | -$13.08M | – |
| Q1 FY2021 | Mar 31, 2021 | -$20.71M | – |
| Q4 FY2020 | Dec 31, 2020 | -$13.11M | -166.3% |
| Q3 FY2020 | Sep 30, 2020 | -$11.15M | – |
| Q2 FY2020 | Jun 30, 2020 | -$10.79M | – |
| Q1 FY2020 | Mar 31, 2020 | -$13.07M | – |
| Q4 FY2019 | Dec 31, 2019 | $19.79M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.06M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.75M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.70M | – |
| Q4 FY2018 | Dec 31, 2018 | -$7.24M | – |
| Q3 FY2018 | Sep 30, 2018 | -$13.73M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.54M | – |
| Q1 FY2018 | Mar 31, 2018 | -$8.22M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.84M | – |
| Q3 FY2017 | Sep 30, 2017 | -$8.63M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.80M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.46M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.67M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.52M | – |
See a number that looks wrong?